Comparison between Original and Reviewed Consensus of European Working Group on Sarcopenia in Older People: A Probabilistic Cross-Sectional Survey among Community-Dwelling Older People

Gerontology ◽  
2021 ◽  
pp. 1-8
Author(s):  
Erik Ramirez ◽  
Rogelio Salas ◽  
Cristina Bouzas ◽  
Rosario Pastor ◽  
Josep A. Tur
Keyword(s):  
Muscle Strength ◽  
Older People ◽  
Muscle Mass ◽  
Working Group ◽  
Handgrip Strength ◽  
Community Dwelling ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
European Working Group ◽  
European Working

<b><i>Introduction:</i></b> The European Working Group on Sarcopenia in Older People (EWGSOP) published a consensus on sarcopenia in 2010 and updated it in 2019 (EWGSOP2) which included the use of specific cut-off points. The aim was to assess how much prevalence of sarcopenia differed between EWGSOP2 and EWGSOP, as well as the use of specific cut-off points to assess differences in presarcopenia versus probable sarcopenia. <b><i>Methods:</i></b> Observational, transversal, and comparative study (<i>n</i> = 1,283 older adults; 57% women). Anthropometrics and handgrip strength were measured, and appendicular skeletal muscle mass equation was defined. Conceptual and methodological definitions of EWGSOP and EWGSOP2 consensus were applied to calculate prevalence of presarcopenia, probable sarcopenia, and sarcopenia. <b><i>Results:</i></b> Using cut-off points recommended for European population, prevalence of sarcopenia with EWGSOP2 was lower (−6.6%; <i>p</i> &#x3c; 0.001) than EWGSOP. The prevalence of probable sarcopenia (EWGSOP2) was higher (+7.8%; <i>p</i> &#x3c; 0.001) than EWGSOP presarcopenia. The agreement between EGWGSOP and EWGSOP2 was moderated (<i>K</i> = 0.45; IC = 0.40–0.51). Using specific-population cut-off points for muscle strength and appendicular muscle mass, the prevalence of probable sarcopenia with EWGSOP2 was higher (46.5%; <i>p</i> &#x3c; 0.001) than EWGSOP (1.8%). The agreement between EGWGSOP and EWGSOP2 was moderated (<i>K</i> = 0.48; IC = 0.42–0.52). <b><i>Conclusion:</i></b> The new EWGSOP2 consensus underestimates the prevalence of sarcopenia, compared with EWGSOP using conventional cut-off points. The prevalence of presarcopenia with EWGSOP (low muscle mass) was lower than probable sarcopenia (low muscle strength) with the new EWGSOP2. In both cases, agreements between EWGSOP2 and EWGSOP were moderated. Discrepancies between the original and new consensus have implications on the primary health setting for identifying old and new cases for prevention and treatment.

scholarly journals Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean Frailty and Aging Cohort Study

2019 ◽  
Vol 48 (6) ◽  
pp. 910-916 ◽  
Author(s):  
Miji Kim ◽  
Chang Won Won
Keyword(s):  
Older Adults ◽  
Cohort Study ◽  
Muscle Strength ◽  
Older People ◽  
Muscle Mass ◽  
Working Group ◽  
Community Dwelling ◽  
European Working ◽  
Definition Of ◽  
Community Dwelling Older Adults

Abstract Background in October 2018, the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) updated their original definition of sarcopenia to reflect the scientific and clinical evidence that has accumulated over the last decade. Objective to determine the prevalence of sarcopenia in a large group of community-dwelling older adults using the EWGSOP2 definition and algorithm. Design a cross-sectional study. Setting the nationwide Korean Frailty and Aging Cohort Study (KFACS). Subjects a total of 2,099 ambulatory community-dwelling older adults, aged 70–84 years (mean age, 75.9 ± 4.0 years; 49.8% women) who were enrolled in the KFACS. Methods physical function was assessed by handgrip strength, usual gait speed, the five-times-sit-to-stand test, the timed up-and-go test, and the Short Physical Performance Battery. Appendicular skeletal muscle mass (ASM) was measured by dual-energy X-ray absorptiometry. Results according to the criteria of the EWGSOP2, the sarcopenia indicators of combined low muscle strength and low muscle quantity were present in 4.6–14.5% of men and 6.7–14.4% of women. The severe sarcopenia indicators of combined low muscle strength, low muscle quantity and low physical performance were present in 0.3–2.2% of men and 0.2–6.2% of women. Using the clinical algorithm with SARC-F as a screening tool, the prevalence of probable sarcopenia (2.2%), confirmed sarcopenia (1.4%) and severe sarcopenia (0.8%) was low. Conclusions the prevalence of sarcopenia among community-dwelling older individuals varied depending on which components of the revised EWGSOP2 definition were used, such as the tools used to measure muscle strength and the ASM indicators for low muscle mass.

scholarly journals Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019

Nutrients ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 547 ◽  
Author(s):  
Julia Traub ◽  
Ina Bergheim ◽  
Martin Eibisberger ◽  
Vanessa Stadlbauer
Keyword(s):  
Liver Cirrhosis ◽  
Muscle Strength ◽  
Diagnostic Criteria ◽  
Muscle Mass ◽  
Working Group ◽  
Handgrip Strength ◽  
Muscle Performance ◽  
European Working Group ◽  
European Working ◽  
High Risk Populations

The European Working group on Sarcopenia in Older People recently updated the diagnostic criteria for sarcopenia. It is yet unclear how these modified criteria influence the rate of diagnosis in high risk populations, such as liver cirrhosis. We therefore assessed if the new diagnostic criteria for sarcopenia impacts on sarcopenia prevalence in liver cirrhosis. Within two years 114 cirrhotic patients were prospectively enrolled in the study. Sarcopenia was determined by muscle strength (handgrip strength), muscle mass (lumbal muscle index) and muscle performance (gait speed). Using the 2019 definition, the rate of pre-sarcopenia was significantly lower (30.7% versus 3.5%) due to the different starting points (2010 muscle mass, 2019 muscle strength) and cut-off values (muscle strength). The change in diagnostic criteria for sarcopenia drastically influences the rate of pre-sarcopenia diagnosis in cirrhotics. To evaluate, which diagnostic criteria should be chosen to diagnose sarcopenia in liver cirrhosis patients, prospective studies are needed.

scholarly journals Prevalence of sarcopenia in community-dwelling older people of Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria

2017 ◽  
Vol 2 (2) ◽  
Author(s):  
María Claudia Espinel-Bermúdez ◽  
Eliseo Ramírez-García ◽  
Carmen García-Peña ◽  
Antoni Salvà-Casanovas ◽  
Liliana Ruiz-Arregui ◽  
...  
Keyword(s):  
Older People ◽  
Mexico City ◽  
Muscle Mass ◽  
Gait Speed ◽  
Working Group ◽  
Handgrip Strength ◽  
Community Dwelling ◽  
European Working ◽  
Community Dwelling Older People ◽  
Mexican Adults

Background: The aim of this study is to determine the prevalence of sarcopenia in community-dwelling older people living in Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria that include muscle mass, muscle strength and physical performance.Methods: The sample population was based on older people (≥60 years) affiliated with the Mexican Institute of Social Security in Mexico City. Data were derived from the database of the “Cohort of Obesity, Sarcopenia and Frailty of Older Mexican Adults” (COSFOMA). Sarcopenia was diagnosed using the EGWSOP criteria: gait speed (4 m) <0.8 m/s; handgrip strength (using a dynamometer) <20 kg in females or <30 kg in males, and muscle mass index (MMI) <6.1 kg/m2 in females or <8.5 kg/m2 in males (using bioimpedance analysis).Results: Thousand hundred seventy-seven subjects were included (median age 68.4 years, 60.2% females). 20.5% had low gait speed (19.1% females and 22.6% males); 62.4% had low handgrip strength (69.9% females and 51.2% males) and 12.3% had low muscle mass (9.9% females and 16.0% males). Only 9.9% of older people with sarcopenia (9.0% females and 11.1% males): 1.9% with severe sarcopenia (1.4% females and 2.6% males) and 8.0% with moderate sarcopenia (7.6% females and 8.5% males).Conclusions: Sarcopenia is present in one of ten community-dwelling older people residing in Mexico City. According to what has been reported in the literature, the prevalence of sarcopenia in older Mexican adults is similar to the community-dwelling population.

scholarly journals AB0154 USAGE OF THE SARC-F QUESTIONNAIRE FOR SARCOPENIA SCREENING IN PATIENTS WITH RHEUMATOID ARTHRITIS

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1104.2-1104
Author(s):  
O. Dobrovolskaya ◽  
N. Toroptsova ◽  
O. Nikitinskaya ◽  
A. Efremova ◽  
N. Demin
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Practice ◽  
Muscle Strength ◽  
Older People ◽  
Working Group ◽  
Handgrip Strength ◽  
Diagnostic Value ◽  
Screening Methods ◽  
European Working Group ◽  
European Working

Background:Sarcopenia, characterized by low muscle strength and low muscle quantity or quality and associated with increased risks of falling and mortality. The prevalence of sarcopenia is 37% among patients with RA [1]. However, in clinical practice settings, sarcopenia among RA patients remains underdiagnosed. The SARC-F questionnaire [2] was recommended by the European Working Group on Sarcopenia in Older People (EWGSOP) before performing muscle strength tests and assessment muscle mass.Objectives:To evaluate the diagnostic value of the SARC-F questionnaire for the screening of sarcopenia (SP) in women with rheumatoid arthritis (RA).Methods:83 women (average age 59±8 years) with RA without aseptic bone necrosis, joint replacement and severe comorbidities were recruited. All patients were interviewed with the SARC-F questionnaire. The summation score ≥ 4 corresponded to cut-off for suspected sarcopenia. Sarcopenia was evaluated using the European Working Group on Sarcopenia in Older People (EWGSOP2), which included dual-energy X-ray absorptiometry (DXA), handgrip strength or chair stand test, and gait speed. The sensitivity, specificity, positive and negative prognostic values of the SARC-F questionnaire were estimated.Results:Confirmed SP was diagnosed in 20 (24%) RA patients, who had low muscle strength and mass. When conventional cut-off point (≥4) for SARC-F questionnaire was applied, only 30% of the patients with SP met this condition (sensitivity 30%, 95% confidence interval [95% CI] 13% to 54%), and 41% of the patients without SP did not meet this condition (specificity 41%, 95% CI 29% to 54%). Positive and negative prognostic values were 14% (95% CI 6% to 29%) and 65% (95% CI 48% to 79%), respectively.Conclusion:The SARC-F questionnaire alone is not adequate for screening of SP in RA patient. It is necessary to develop other simple screening methods that can easily be carried out in real clinical practice to identify individuals with possible SP for further diagnostic tests.References:[1]Torii M, Hashimoto M, Hanai A, et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Modern Rheumatology, 2018;29(4):589-595. doi:10.1080/14397595.2018.1510565.[2]Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169.Disclosure of Interests:None declared

Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People

2019 ◽  
Vol 74 (4) ◽  
pp. 573-580 ◽  
Author(s):  
Nathalia Perleberg Bachettini ◽  
Renata Moraes Bielemann ◽  
Thiago Gonzalez Barbosa-Silva ◽  
Ana Maria Baptista Menezes ◽  
Elaine Tomasi ◽  
...  
Keyword(s):  
Older Adults ◽  
Older People ◽  
Diagnostic Criteria ◽  
Working Group ◽  
Community Dwelling ◽  
European Working Group ◽  
European Working ◽  
Community Dwelling Older Adults

scholarly journals Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment

2014 ◽  
Vol 44 (2) ◽  
pp. 334-338 ◽  
Author(s):  
Roberto Alves Lourenço ◽  
Mario Pérez-Zepeda ◽  
Luis Gutiérrez-Robledo ◽  
Francisco J. García-García ◽  
Leocadio Rodríguez Mañas
Keyword(s):  
Older Adults ◽  
Older People ◽  
Muscle Mass ◽  
Working Group ◽  
European Working Group ◽  
European Working

scholarly journals Prevalence of sarcopenia in an elderly population in rural South India: a cross-sectional study

F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 175
Author(s):  
Nishat Shaikh ◽  
R Harshitha ◽  
Madhavi Bhargava
Keyword(s):  
Muscle Strength ◽  
Muscle Mass ◽  
Rural Areas ◽  
Large Scale ◽  
Elderly Population ◽  
South India ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Skeletal Mass ◽  
European Working

Background: Sarcopenia is a condition common in the elderly characterized by progressive and generalized loss of skeletal muscle mass and strength leading to poor quality of life. According to a working definition proposed by the European Working Group on Sarcopenia in Older People (EWGSOP), the criteria for a diagnosis of sarcopenia is based on documentation of low muscle mass with either poor muscle strength or low physical performance. The objective of the present study was to determine the prevalence of sarcopenia in the rural elderly population of South India. Methods: We conducted a cross-sectional survey of 240 elderly people, 60 years and above, 118 men and 122 women, in rural areas of Dakshina Kannada district. We measured their height, weight, gait speed (using an 8-feet walk test) and muscle strength (using a handgrip dynamometer). Appendicular skeletal mass was calculated using height and weight adjusted for sex and Asian people using the Lee formula. Results: Sarcopenia was found in 34 (14.2%) participants. Of all those having sarcopenia, 27 (79.4%) were ≤75 years, 30 (88.2%) were women, 27 (79.4%) were married, 23 (67.6%) had below poverty line status. Conclusions: The prevalence of sarcopenia found in the present study was 14.2% in an elderly population more than 60 years of age and was found to be more in women. Large-scale multi-centric community-based surveys will help determine the actual burden of sarcopenia in India.

scholarly journals Prevalence of sarcopenia in community-dwelling older adults in Ireland: comparison of EWGSOP1 and EWGSOP2 definitions

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Caoileann Murphy ◽  
Aoibheann McMorrow ◽  
Ellen Flanagan ◽  
Helen Cummins ◽  
Sinead McCarthy ◽  
...  
Keyword(s):  
Older Adults ◽  
Muscle Strength ◽  
Muscle Mass ◽  
Physical Performance ◽  
Clinical Investigation ◽  
Community Dwelling ◽  
Muscle Disease ◽  
Cross Sectional ◽  
European Working ◽  
Community Dwelling Older Adults

AbstractSarcopenia is a muscle disease rooted in adverse muscle changes that accrue across a lifetime. It is an independent risk factor for numerous adverse health outcomes. In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a definition for the identification of people with sarcopenia (EWGSOP1). In 2018, this definition was updated based on the newest evidence (EWGSOP2), with the focus now on low muscle strength rather than low muscle quantity as the key characteristic of sarcopenia. In addition, EWGSOP2 provides clear cut-off points for measurements of variables that identify sarcopenia. The aim of this study was to determine the prevalence of sarcopenia among community-dwelling older adults in Ireland for the first time and to assess agreement between the EWGSOP1 and EWGSOP2 definitions. In a cross-sectional analysis, 490 community-dwelling adults (age 78.4 ± 8.0 y, body mass index 27.6 ± 5.1 kg/m2) were assessed. Skeletal muscle mass was estimated using bioelectrical impedance analysis, muscle strength was measured via handgrip dynamometry and physical performance via the Short Physical Performance Battery. Sarcopenia was defined according to both the 2010 criteria (EWGSOP1) and the updated 2018 criteria (EWGSOP2). Using the EWGSOP1 criteria, the prevalence of sarcopenia was 7.1% (2.6% sarcopenia, 4.5% severe sarcopenia) and 3.6% were classified as pre-sarcopenic (low muscle mass without a decrement in strength or physical performance). Using the EWGSOP2 criteria, the prevalence of sarcopenia was 5.5% (1.6% sarcopenia, 3.9% severe sarcopenia) and 23.4 % were classified as having low strength but without a decrement in muscle mass. Five of the participants who were classified as sarcopenic (2 sarcopenia, 3 severe sarcopenia) by EWGSOP1 were classified as “normal” using the EWGSOP2 criteria. In conclusion, the prevalence of sarcopenia in community-dwelling older adults in Ireland is in line with the prevalence reported in other European countries using the EWGSOP1 criteria (3.3–11.4 %). To our knowledge this is the first study to compare the prevalence based on the EWGSOP1 and the EWGSOP2 criteria. We report a slightly lower prevalence using the EWGSOP2 definition compared to the EWGSOP1 definition. Importantly however, in contrast to EWGSOP1, the EWGSOP2 definition identified a substantial proportion of older adults with poor strength in the absence of overt sarcopenia (23.4%). These older adults represent a group who would benefit from further clinical investigation and intervention.

scholarly journals Inflammatory potential of the diet and risk of sarcopenia and its components

2020 ◽  
Author(s):  
Amir Bagheri ◽  
Sanaz Soltani ◽  
Rezvan Hashemi ◽  
Ramin Heshmat ◽  
Ahmadreza Dorosty Motlagh ◽  
...  
Keyword(s):  
Muscle Mass ◽  
Handgrip Strength ◽  
Dietary Assessment ◽  
Large Body ◽  
Population Based ◽  
Cross Sectional Study ◽  
Community Dwelling ◽  
Cross Sectional ◽  
Abnormal Gait ◽  
European Working

Abstract Background: Despite a large body of evidence on the link between dietary inflammatory index (DII) and several chronic conditions, limited data are available about the association of DII and sarcopenia. This study aimed to examine the relationship between inflammatory potential of the diet (as measured by DII) and sarcopenia and its components among community-dwelling elderly population.Methods: This population-based cross-sectional study was performed in 2011 among 300 elderly people (150 men and 150 women) aged ≥55 years, who were selected using cluster random sampling method. Dietary assessment was done using a pre-tested food frequency questionnaire. Energy-adjusted DII was calculated based on earlier studies. Sarcopenia and its components were determined based on the European Working Group on Sarcopenia (EWGSOP) definition.Results: Mean age of study participants was 66.7 ± 7.7 y. Subjects in the highest tertile of DII score (i.e. those with a more pro-inflammatory diet) were more likely to be older (P=0.02). The prevalence of sarcopenia (P=0.016) and low muscle mass (P=0.041) was significantly higher among subjects in the top tertile compared with those in the bottom tertile of DII. After adjustment for potential confounders, those with the highest DII were 2.18 times (95% CI: 1.01-4.74) more likely to have sarcopenia than those with the lowest DII. With regard to components of sarcopenia, subjects in the top tertile of DII had not significantly greater odds of low muscle mass (OR: 1.38; 95% CI: 0.72-2.63), abnormal handgrip strength (OR: 0.97; 95% CI: 0.49-1.89), and abnormal gait speed (OR: 1.61; 95% CI: 0.84-3.08) than those in the bottom tertile.Conclusions: In conclusion, a diet with more pro-inflammatory potential was associated with a greater odds of sarcopenia. Further studies are required to confirm these findings.

Sign in / Sign up

Export Citation Format

Share Document